I guess its always a possibility, with Strandline emerging as the primary competitor to Iluka there may be moves to consolidate market position by snapping up smaller players (IMA/DRX). Certainly the 3 month average SP for Image is very low right now and so its an ideal time to try and acquire the company with a relatively low ball offer.
- Forums
- ASX - By Stock
- zircon price market research
I guess its always a possibility, with Strandline emerging as...
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMA (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.4¢ |
Change
-0.006(6.67%) |
Mkt cap ! $92.58M |
Open | High | Low | Value | Volume |
8.8¢ | 8.8¢ | 8.3¢ | $109.6K | 1.294M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23529 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 4770 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23529 | 0.085 |
1 | 2000 | 0.084 |
1 | 12048 | 0.083 |
3 | 147500 | 0.082 |
7 | 183500 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 4770 | 1 |
0.098 | 289999 | 4 |
0.100 | 225020 | 5 |
0.105 | 352000 | 3 |
0.110 | 398530 | 6 |
Last trade - 11.50am 13/11/2024 (20 minute delay) ? |
Featured News
IMA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online